ID   SARM1_CAEEL             Reviewed;         981 AA.
AC   Q86DA5; O17801; O17802; Q19373; Q7JMF4; Q7JMF5;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-OCT-2020, sequence version 2.
DT   18-JUN-2025, entry version 169.
DE   RecName: Full=NAD(+) hydrolase tir-1 {ECO:0000305};
DE            Short=NADase tir-1 {ECO:0000305};
DE            EC=3.2.2.6 {ECO:0000269|PubMed:31439792};
DE   AltName: Full=Neuronal symmetry protein 2;
DE   AltName: Full=SARM1 homolog;
DE   AltName: Full=Sterile alpha and TIR motif-containing protein tir-1 {ECO:0000303|PubMed:15048112};
GN   Name=tir-1 {ECO:0000303|PubMed:15048112,
GN   ECO:0000312|WormBase:F13B10.1c};
GN   Synonyms=nsy-2 {ECO:0000312|WormBase:F13B10.1c};
GN   ORFNames=F13B10.1 {ECO:0000312|WormBase:F13B10.1c};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION, TISSUE SPECIFICITY, HOMODIMERIZATION, AND INTERACTION WITH RAB-1
RP   AND PAL-1.
RX   PubMed=15048112; DOI=10.1038/ni1060;
RA   Couillault C., Pujol N., Reboul J., Sabatier L., Guichou J.-F., Kohara Y.,
RA   Ewbank J.J.;
RT   "TLR-independent control of innate immunity in Caenorhabditis elegans by
RT   the TIR domain adaptor protein TIR-1, an ortholog of human SARM.";
RL   Nat. Immunol. 5:488-494(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=15123841; DOI=10.1073/pnas.0308625101;
RA   Liberati N.T., Fitzgerald K.A., Kim D.H., Feinbaum R., Golenbock D.T.,
RA   Ausubel F.M.;
RT   "Requirement for a conserved Toll/interleukin-1 resistance domain protein
RT   in the Caenorhabditis elegans immune response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:6593-6598(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH
RP   UNC-43.
RX   PubMed=15625192; DOI=10.1101/gad.1276505;
RA   Chuang C.-F., Bargmann C.I.;
RT   "A Toll-interleukin 1 repeat protein at the synapse specifies asymmetric
RT   odorant receptor expression via ASK1 MAPKKK signaling.";
RL   Genes Dev. 19:270-281(2005).
RN   [5]
RP   REVIEW.
RX   PubMed=18089857; DOI=10.1126/stke.4172007pe73;
RA   Dalod M.;
RT   "Studies of SARM1 uncover similarities between immune and neuronal
RT   responses to danger.";
RL   Sci. STKE 2007:PE73-PE73(2007).
RN   [6]
RP   FUNCTION.
RX   PubMed=18394898; DOI=10.1016/j.cub.2008.02.079;
RA   Pujol N., Cypowyj S., Ziegler K., Millet A., Astrain A., Goncharov A.,
RA   Jin Y., Chisholm A.D., Ewbank J.J.;
RT   "Distinct innate immune responses to infection and wounding in the C.
RT   elegans epidermis.";
RL   Curr. Biol. 18:481-489(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=21212236; DOI=10.1534/genetics.110.124883;
RA   Hayakawa T., Kato K., Hayakawa R., Hisamoto N., Matsumoto K., Takeda K.,
RA   Ichijo H.;
RT   "Regulation of anoxic death in Caenorhabditis elegans by mammalian
RT   apoptosis signal-regulating kinase (ASK) family proteins.";
RL   Genetics 187:785-792(2011).
RN   [8]
RP   FUNCTION.
RX   PubMed=22363008; DOI=10.1126/science.1215156;
RA   Blum E.S., Abraham M.C., Yoshimura S., Lu Y., Shaham S.;
RT   "Control of nonapoptotic developmental cell death in Caenorhabditis elegans
RT   by a polyglutamine-repeat protein.";
RL   Science 335:970-973(2012).
RN   [9]
RP   FUNCTION.
RX   PubMed=23505381; DOI=10.1371/journal.pgen.1003324;
RA   Xie Y., Moussaif M., Choi S., Xu L., Sze J.Y.;
RT   "RFX transcription factor DAF-19 regulates 5-HT and innate immune responses
RT   to pathogenic bacteria in Caenorhabditis elegans.";
RL   PLoS Genet. 9:e1003324-e1003324(2013).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25204677; DOI=10.1186/s12915-014-0064-6;
RA   Crook-McMahon H.M., Olahova M., Button E.L., Winter J.J., Veal E.A.;
RT   "Genome-wide screening identifies new genes required for stress-induced
RT   phase 2 detoxification gene expression in animals.";
RL   BMC Biol. 12:64-64(2014).
RN   [11]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=27671644; DOI=10.1073/pnas.1601506113;
RA   Summers D.W., Gibson D.A., DiAntonio A., Milbrandt J.;
RT   "SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate
RT   injury-induced SARM1 activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:E6271-E6280(2016).
RN   [12]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=31439792; DOI=10.1126/science.aax1911;
RA   Horsefield S., Burdett H., Zhang X., Manik M.K., Shi Y., Chen J., Qi T.,
RA   Gilley J., Lai J.S., Rank M.X., Casey L.W., Gu W., Ericsson D.J., Foley G.,
RA   Hughes R.O., Bosanac T., von Itzstein M., Rathjen J.P., Nanson J.D.,
RA   Boden M., Dry I.B., Williams S.J., Staskawicz B.J., Coleman M.P., Ve T.,
RA   Dodds P.N., Kobe B.;
RT   "NAD+ cleavage activity by animal and plant TIR domains in cell death
RT   pathways.";
RL   Science 365:793-799(2019).
CC   -!- FUNCTION: NAD(+) hydrolase, which plays a key role in non-apoptotic
CC       cell death by regulating NAD(+) metabolism (PubMed:27671644). In
CC       response to stress, homooligomerizes and catalyzes cleavage of NAD(+)
CC       into ADP-D-ribose (ADPR) and nicotinamide; NAD(+) cleavage promoting
CC       non-apoptotic neuronal cell death (PubMed:31439792). In males, involved
CC       in non-apoptotic death of the linker cell which guides gonad elongation
CC       during larval development (PubMed:22363008). Required for both innate
CC       immune response and specification of AWC(OFF) neuron (PubMed:15048112,
CC       PubMed:15123841, PubMed:15625192). During late embryogenesis, it acts
CC       downstream of CAMKII (unc-43) to regulate specification of asymmetric
CC       odorant receptors in AWC(OFF) neuron via the nsy-1/ASK1 pmk-1/p38 MAP
CC       kinase signaling cascade. Required to localize nsy-1 to postsynaptic
CC       regions of AWC neuron, suggesting that it may act by assembling a
CC       signaling complex that regulate odorant receptor expression
CC       (PubMed:15625192). Also plays a central role in resistance to infection
CC       to a broad range of bacterial and fungi pathogens, possibly by
CC       activating pmk-1, independently of the NF-kappa-B pathway. Required for
CC       expression of antimicrobial peptides nlp-29 and nlp-31
CC       (PubMed:15048112, PubMed:15123841). Its role in immune response and
CC       neuron specification may be mediated by the same nsy-1/ASK1 pmk-1/p38
CC       MAP kinase cascade signaling pathway (PubMed:15048112, PubMed:15123841,
CC       PubMed:15625192). Involved in the response to anoxic conditions
CC       probably by activating the p38 pathway composed of nsy-1/sek-1/pmk-1
CC       (PubMed:21212236). Involved in regulation of the serotonergic response
CC       of ADF neurons to pathogenic food (PubMed:23505381). In addition, plays
CC       a role in the up-regulation of gcs-1 upon arsenite treatment, most
CC       likely through activation of pmk-1, to confer protection against
CC       toxicity induced by heavy metals (PubMed:25204677).
CC       {ECO:0000269|PubMed:15048112, ECO:0000269|PubMed:15123841,
CC       ECO:0000269|PubMed:15625192, ECO:0000269|PubMed:21212236,
CC       ECO:0000269|PubMed:22363008, ECO:0000269|PubMed:23505381,
CC       ECO:0000269|PubMed:25204677, ECO:0000269|PubMed:27671644,
CC       ECO:0000269|PubMed:31439792}.
CC   -!- FUNCTION: [Isoform b]: Regulates expression of antimicrobial peptide
CC       nlp-29 in response to fungal infection or physical injury.
CC       {ECO:0000269|PubMed:18394898}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + H2O = ADP-D-ribose + nicotinamide + H(+);
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000269|PubMed:31439792};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000269|PubMed:31439792};
CC   -!- SUBUNIT: Homodimer (PubMed:15048112, PubMed:27671644). Interacts with
CC       rab-1, pal-1 and unc-43 (PubMed:15048112, PubMed:15625192).
CC       {ECO:0000269|PubMed:15048112, ECO:0000269|PubMed:15625192,
CC       ECO:0000269|PubMed:27671644}.
CC   -!- INTERACTION:
CC       Q86DA5; Q86DA5: tir-1; NbExp=3; IntAct=EBI-319472, EBI-319472;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15625192}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=c {ECO:0000312|WormBase:F13B10.1c};
CC         IsoId=Q86DA5-1; Sequence=Displayed;
CC       Name=a {ECO:0000312|WormBase:F13B10.1a};
CC         IsoId=Q86DA5-2; Sequence=VSP_060730, VSP_060731;
CC       Name=b {ECO:0000312|WormBase:F13B10.1b};
CC         IsoId=Q86DA5-3; Sequence=VSP_060732;
CC       Name=d {ECO:0000312|WormBase:F13B10.1d};
CC         IsoId=Q86DA5-4; Sequence=VSP_013613;
CC       Name=e {ECO:0000312|WormBase:F13B10.1e};
CC         IsoId=Q86DA5-5; Sequence=VSP_060733, VSP_060731;
CC   -!- TISSUE SPECIFICITY: Highly expressed in hypodermis. Localizes to
CC       postsynaptic regions of axons. {ECO:0000269|PubMed:15048112,
CC       ECO:0000269|PubMed:15625192}.
CC   -!- DOMAIN: The SAM domains mediate the localization to postsynaptic
CC       regions of neurons. {ECO:0000269|PubMed:15625192}.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000250|UniProtKB:Q6SZW1}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown results in reduced
CC       survival and reduced pmk-1 phosphorylation in response to the heavy
CC       metal arsenite. {ECO:0000269|PubMed:25204677}.
CC   -!- SIMILARITY: Belongs to the SARM1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284603; CAA90181.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAA90182.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAD90174.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAE47466.1; -; Genomic_DNA.
DR   EMBL; BX284603; CAE47467.1; -; Genomic_DNA.
DR   PIR; T20816; T20816.
DR   PIR; T20817; T20817.
DR   RefSeq; NP_001021251.2; NM_001026080.5. [Q86DA5-1]
DR   RefSeq; NP_001021252.1; NM_001026081.2.
DR   RefSeq; NP_001021253.1; NM_001026082.2.
DR   RefSeq; NP_001367074.1; NM_001381812.1. [Q86DA5-5]
DR   RefSeq; NP_001370174.1; NM_001384059.3. [Q86DA5-4]
DR   RefSeq; NP_497784.1; NM_065383.6. [Q86DA5-2]
DR   RefSeq; NP_497785.1; NM_065384.7. [Q86DA5-3]
DR   PDB; 8P2L; EM; 2.68 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=771-926.
DR   PDB; 8P2M; EM; 3.82 A; A/B/C/D/E/F/G/H/I=216-926.
DR   PDBsum; 8P2L; -.
DR   PDBsum; 8P2M; -.
DR   AlphaFoldDB; Q86DA5; -.
DR   EMDB; EMD-17369; -.
DR   EMDB; EMD-17370; -.
DR   SMR; Q86DA5; -.
DR   BioGRID; 40740; 27.
DR   DIP; DIP-26569N; -.
DR   FunCoup; Q86DA5; 1127.
DR   IntAct; Q86DA5; 18.
DR   STRING; 6239.F13B10.1f.1; -.
DR   iPTMnet; Q86DA5; -.
DR   PaxDb; 6239-F13B10.1c; -.
DR   PeptideAtlas; Q86DA5; -.
DR   EnsemblMetazoa; F13B10.1a.1; F13B10.1a.1; WBGene00006575. [Q86DA5-2]
DR   EnsemblMetazoa; F13B10.1a.2; F13B10.1a.2; WBGene00006575. [Q86DA5-2]
DR   EnsemblMetazoa; F13B10.1b.1; F13B10.1b.1; WBGene00006575. [Q86DA5-3]
DR   EnsemblMetazoa; F13B10.1c.1; F13B10.1c.1; WBGene00006575. [Q86DA5-1]
DR   EnsemblMetazoa; F13B10.1d.1; F13B10.1d.1; WBGene00006575. [Q86DA5-4]
DR   EnsemblMetazoa; F13B10.1d.2; F13B10.1d.2; WBGene00006575. [Q86DA5-4]
DR   EnsemblMetazoa; F13B10.1d.3; F13B10.1d.3; WBGene00006575. [Q86DA5-4]
DR   EnsemblMetazoa; F13B10.1e.1; F13B10.1e.1; WBGene00006575. [Q86DA5-5]
DR   EnsemblMetazoa; F13B10.1e.2; F13B10.1e.2; WBGene00006575. [Q86DA5-5]
DR   EnsemblMetazoa; F13B10.1e.3; F13B10.1e.3; WBGene00006575. [Q86DA5-5]
DR   GeneID; 175502; -.
DR   KEGG; cel:CELE_F13B10.1; -.
DR   UCSC; F13B10.1e.2; c. elegans. [Q86DA5-1]
DR   AGR; WB:WBGene00006575; -.
DR   CTD; 175502; -.
DR   WormBase; F13B10.1a; CE20681; WBGene00006575; tir-1. [Q86DA5-2]
DR   WormBase; F13B10.1b; CE15818; WBGene00006575; tir-1. [Q86DA5-3]
DR   WormBase; F13B10.1c; CE50801; WBGene00006575; tir-1. [Q86DA5-1]
DR   WormBase; F13B10.1d; CE35712; WBGene00006575; tir-1. [Q86DA5-4]
DR   WormBase; F13B10.1e; CE35713; WBGene00006575; tir-1. [Q86DA5-5]
DR   eggNOG; KOG3678; Eukaryota.
DR   GeneTree; ENSGT00390000004155; -.
DR   InParanoid; Q86DA5; -.
DR   OrthoDB; 202764at2759; -.
DR   PhylomeDB; Q86DA5; -.
DR   SignaLink; Q86DA5; -.
DR   PRO; PR:Q86DA5; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00006575; Expressed in pharyngeal muscle cell (C elegans) and 3 other cell types or tissues.
DR   ExpressionAtlas; Q86DA5; baseline and differential.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:1904115; C:axon cytoplasm; IDA:WormBase.
DR   GO; GO:0044297; C:cell body; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003953; F:NAD+ nucleosidase activity; IDA:UniProtKB.
DR   GO; GO:0061809; F:NAD+ nucleosidase activity, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0019901; F:protein kinase binding; IPI:WormBase.
DR   GO; GO:0035591; F:signaling adaptor activity; IDA:WormBase.
DR   GO; GO:0031267; F:small GTPase binding; IPI:WormBase.
DR   GO; GO:0140367; P:antibacterial innate immune response; IMP:WormBase.
DR   GO; GO:0001708; P:cell fate specification; IMP:WormBase.
DR   GO; GO:0007267; P:cell-cell signaling; IMP:WormBase.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:WormBase.
DR   GO; GO:0050832; P:defense response to fungus; IMP:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB.
DR   GO; GO:0019677; P:NAD catabolic process; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0034128; P:negative regulation of MyD88-independent toll-like receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:WormBase.
DR   GO; GO:0008104; P:protein localization; IMP:WormBase.
DR   GO; GO:0048678; P:response to axon injury; IDA:UniProtKB.
DR   GO; GO:0042427; P:serotonin biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd09501; SAM_SARM1-like_repeat1; 1.
DR   CDD; cd09502; SAM_SARM1-like_repeat2; 1.
DR   CDD; cd24153; SARM1_N; 1.
DR   FunFam; 1.10.150.50:FF:000043; Sterile alpha and TIR motif-containing 1; 1.
DR   FunFam; 1.10.150.50:FF:000101; Sterile alpha and TIR motif-containing protein tir-1; 1.
DR   FunFam; 1.25.10.10:FF:001252; Sterile alpha and TIR motif-containing protein tir-1; 1.
DR   FunFam; 3.40.50.10140:FF:000023; Sterile alpha and TIR motif-containing protein tir-1; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   Gene3D; 3.40.50.10140; Toll/interleukin-1 receptor homology (TIR) domain; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR039184; SARM1.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR22998:SF1; NAD(+) HYDROLASE SARM1; 1.
DR   PANTHER; PTHR22998; SARM1; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   Pfam; PF13676; TIR_2; 1.
DR   SMART; SM00454; SAM; 2.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 2.
DR   SUPFAM; SSF52200; Toll/Interleukin receptor TIR domain; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Developmental protein;
KW   Differentiation; Hydrolase; Immunity; Innate immunity; NAD; Neurogenesis;
KW   Reference proteome; Repeat.
FT   CHAIN           1..981
FT                   /note="NAD(+) hydrolase tir-1"
FT                   /id="PRO_0000097587"
FT   DOMAIN          614..678
FT                   /note="SAM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          684..750
FT                   /note="SAM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          760..857
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          74..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          173..225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          908..981
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        12..23
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        74..85
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        87..97
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        98..114
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        115..128
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        182..200
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        908..939
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        954..963
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        972..981
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        842
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   BINDING         769..770
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /ligand_note="substrate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   VAR_SEQ         1..638
FT                   /note="Missing (in isoform d)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_013613"
FT   VAR_SEQ         1..569
FT                   /note="MLPNRKPPRPSPSFQSLNNNNQRFPLRRSLKIAQAHSLPTVPSEDAKDDDLI
FT                   TPELSTDFDFREIQHRYLMALQNEQDGETTSTDDAFFELDDDDDLSSPSVPGSPVDPPS
FT                   ISVPLPPKSAPPCPTQPAPLTNGDLYPTILSNGTPIPNGRITPALSTVSVSLIHEARLQ
FT                   QSLSTPCNGSEEEMHNGQVRKESEYRRFKSEGSTAGASLPAAEKTHMDELSPVDQRSTS
FT                   GTARFLIQQDSVVNPSTKMSNTEQVAMMHTLKTKLSKYQAMMDKAFEEIAKVEDANIIE
FT                   GCTIVRKLMRKVWNTPKVSADLANALCDYLRDRDYFDKLIKMFISPNTAACDQVRMECG
FT                   KVLEECTSSANLEYIVNKSYTKKIMIVAMKLNKTPDQQRLSLSLIGNLFKHSNAVSLSL
FT                   IETDVIDHIILTFKRAPECPDILRHAALALANILLYTCFEGKKKIIQKKIPEWLFFLAS
FT                   QADDVTRYYACIAVCTIVSVKEFEPLVRKSDTMKLVEPFLQVHDPATFARDYHKYAQGN
FT                   TKEWLERLLPMLQPSRRREARSVAAFHFTLEATIKKEQNKLDVFQ -> MCALVSSPMV
FT                   SLPFNENVAPECRRNLLPRFAAVSPRPKAAVTPFVSTPSSSSITSFPYSLKLSNSNSNC
FT                   SSLSRPSSLTDLPILLRDVEDQMYDDDETPIIPCGSPSSSNSMLAQIQFHPPPTEMNSP
FT                   LKTSLKKLPMKTALVIRPQMFVKENSVQLERFRKSKTRRFFHPYAK (in isoform
FT                   b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060732"
FT   VAR_SEQ         1..183
FT                   /note="Missing (in isoform e)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060733"
FT   VAR_SEQ         1..83
FT                   /note="MLPNRKPPRPSPSFQSLNNNNQRFPLRRSLKIAQAHSLPTVPSEDAKDDDLI
FT                   TPELSTDFDFREIQHRYLMALQNEQDGETTS -> MGEEILTERNQLSRQDASCFRSPR
FT                   SPLGR (in isoform a)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060730"
FT   VAR_SEQ         954
FT                   /note="F -> FFSV (in isoform a and isoform e)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060731"
SQ   SEQUENCE   981 AA;  110556 MW;  B114E320A3FF6CCA CRC64;
     MLPNRKPPRP SPSFQSLNNN NQRFPLRRSL KIAQAHSLPT VPSEDAKDDD LITPELSTDF
     DFREIQHRYL MALQNEQDGE TTSTDDAFFE LDDDDDLSSP SVPGSPVDPP SISVPLPPKS
     APPCPTQPAP LTNGDLYPTI LSNGTPIPNG RITPALSTVS VSLIHEARLQ QSLSTPCNGS
     EEEMHNGQVR KESEYRRFKS EGSTAGASLP AAEKTHMDEL SPVDQRSTSG TARFLIQQDS
     VVNPSTKMSN TEQVAMMHTL KTKLSKYQAM MDKAFEEIAK VEDANIIEGC TIVRKLMRKV
     WNTPKVSADL ANALCDYLRD RDYFDKLIKM FISPNTAACD QVRMECGKVL EECTSSANLE
     YIVNKSYTKK IMIVAMKLNK TPDQQRLSLS LIGNLFKHSN AVSLSLIETD VIDHIILTFK
     RAPECPDILR HAALALANIL LYTCFEGKKK IIQKKIPEWL FFLASQADDV TRYYACIAVC
     TIVSVKEFEP LVRKSDTMKL VEPFLQVHDP ATFARDYHKY AQGNTKEWLE RLLPMLQPSR
     RREARSVAAF HFTLEATIKK EQNKLDVFQE IGAIQALKEV ASSPDEVAAK FASEALTVIG
     EEVPYKLAQQ VPGWTCADVQ YWVKKIGFEE YVEKFAKQMV DGDLLLQLTE NDLKHDVGMI
     SGLHRKRFLR ELQTLKVAAD YSSVDESNLD NFLMGLSPEL SVYTYQMLTN GVNRSLLSSL
     TDEMMQNACG ITNPIHRLKL TQAFETAKHP DDVEVAMLSK QIDVFISYRR STGNQLASLI
     KVLLQLRGYR VFIDVDKLYA GKFDSSLLKN IQAAKHFILV LTPNSLDRLL NDDNCEDWVH
     KELKCAFEHQ KNIIPIFDTA FEFPTKEDQI PNDIRMITKY NGVKWVHDYQ DACMAKVVRF
     ITGELNRTTP TTKEMPSISR KTTQQRWQTT NTVSRTGPSR SIGGPRMEPP TPTFTPTGSQ
     ERATSTRRKI QPSASTTSDR N
//
